Published in:
Volume 9 / Year 2020 / Issue 2

Policy recommendations for a sustainable biosimilars market: lessons from Europe

Author(s): ,
Page: 76-83

Abstract: Approximately 25% of all new medicines approved in recent years and in development today are biologicals. The complexity of biologicals, the investment needed to meet ever more stringent regulatory… Read More »

Go Back Print